1-13 of 13
John F. Thompson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

Available to Purchase
Andrew W. Hahn, Ashley V. Menk, Dayana B. Rivadeneira, Ryan C. Augustin, Mingchu Xu, Jun Li, Xiaogang Wu, Aditya K. Mishra, Tuba N. Gide, Camelia Quek, Yan Zang, Christine N. Spencer, Alexander M. Menzies, Carrie R. Daniel, Courtney W. Hudgens, Theodore Nowicki, Lauren E. Haydu, M.A. Wadud Khan, Vancheswaran Gopalakrishnan, Elizabeth M. Burton, Jared Malke, Julie M. Simon, Chantale Bernatchez, Nagireddy Putluri, Scott E. Woodman, Y.N. Vashisht Gopal, Renato Guerrieri, Grant M. Fischer, Jian Wang, Khalida M. Wani, John F. Thompson, Jeffrey E. Lee, Patrick Hwu, Nadim Ajami, Jeffrey E. Gershenwald, Georgina V. Long, Richard A. Scolyer, Michael T. Tetzlaff, Alexander J. Lazar, Dirk Schadendorf, Jennifer A. Wargo, John M. Kirkwood, Ralph J. DeBerardinis, Han Liang, Andrew Futreal, Jianhua Zhang, James S. Wilmott, Weiyi Peng, Michael A. Davies, Greg M. Delgoffe, Yana G. Najjar, Jennifer L. McQuade
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (1): 154–164.
https://doi.org/10.1158/1078-0432.CCR-22-2661
Published: 04 January 2023
View articletitled, Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
Open the PDF for Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma in another window
Includes: Supplementary data
Journal Articles

Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical Trials

Free
Jarem Edwards, Annie Tasker, Inês Pires da Silva, Camelia Quek, Marcel Batten, Angela Ferguson, Ruth Allen, Benjamin Allanson, Robyn P.M. Saw, John F. Thompson, Alexander M. Menzies, Umaimainthan Palendira, James S. Wilmott, Georgina V. Long, Richard A. Scolyer
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (11): 3247–3258.
https://doi.org/10.1158/1078-0432.CCR-18-4011
Published: 03 June 2019
View articletitled, Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical Trials
Open the PDF for Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical Trials in another window
Includes: Supplementary data
Journal Articles

CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment

Free
Jarem Edwards, James S. Wilmott, Jason Madore, Tuba Nur Gide, Camelia Quek, Annie Tasker, Angela Ferguson, Jinbiao Chen, Rehana Hewavisenti, Peter Hersey, Thomas Gebhardt, Wolfgang Weninger, Warwick J. Britton, Robyn P.M. Saw, John F. Thompson, Alexander M. Menzies, Georgina V. Long, Richard A. Scolyer, Umaimainthan Palendira
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (13): 3036–3045.
https://doi.org/10.1158/1078-0432.CCR-17-2257
Published: 01 July 2018
View articletitled, CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment
Open the PDF for CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment in another window
Includes: Supplementary data
Journal Articles

PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors

Free
Hojabr Kakavand, Robert V. Rawson, Gulietta M. Pupo, Jean Y. H. Yang, Alexander M. Menzies, Matteo S. Carlino, Richard F. Kefford, Julie R. Howle, Robyn P.M. Saw, John F. Thompson, James S. Wilmott, Georgina V. Long, Richard A. Scolyer, Helen Rizos
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (20): 6054–6061.
https://doi.org/10.1158/1078-0432.CCR-16-1688
Published: 12 October 2017
View articletitled, PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors
Open the PDF for PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors in another window
Includes: Supplementary data
Journal Articles

Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma

Free
Ricardo E. Vilain, Alexander M. Menzies, James S. Wilmott, Hojabr Kakavand, Jason Madore, Alexander Guminski, Elizabeth Liniker, Benjamin Y. Kong, Adam J. Cooper, Julie R. Howle, Robyn P.M. Saw, Valerie Jakrot, Serigne Lo, John F. Thompson, Matteo S. Carlino, Richard F. Kefford, Georgina V. Long, Richard A. Scolyer
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (17): 5024–5033.
https://doi.org/10.1158/1078-0432.CCR-16-0698
Published: 31 August 2017
View articletitled, Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma
Open the PDF for Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma in another window
Includes: Supplementary data
Journal Articles

PD-L1 Negative Status is Associated with Lower Mutation Burden, Differential Expression of Immune-Related Genes, and Worse Survival in Stage III Melanoma

Free
Jason Madore, Dario Strbenac, Ricardo Vilain, Alexander M. Menzies, Jeen Y. H. Yang, John F. Thompson, Georgina V. Long, Graham J. Mann, Richard A. Scolyer, James S. Wilmott
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (15): 3915–3923.
https://doi.org/10.1158/1078-0432.CCR-15-1714
Published: 31 July 2016
View articletitled, PD-L1 Negative Status is Associated with Lower Mutation Burden, Differential Expression of Immune-Related Genes, and Worse Survival in Stage III Melanoma
Open the PDF for PD-L1 Negative Status is Associated with Lower Mutation Burden, Differential Expression of Immune-Related Genes, and Worse Survival in Stage III Melanoma in another window
Includes: Supplementary data
Journal Articles

PD-L1 Expression and Tumor-Infiltrating Lymphocytes Define Different Subsets of MAPK Inhibitor–Treated Melanoma Patients

Free
Hojabr Kakavand, James S. Wilmott, Alexander M. Menzies, Ricardo Vilain, Lauren E. Haydu, Jennifer H. Yearley, John F. Thompson, Richard F. Kefford, Peter Hersey, Georgina V. Long, Richard A. Scolyer
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (14): 3140–3148.
https://doi.org/10.1158/1078-0432.CCR-14-2023
Published: 14 July 2015
View articletitled, PD-L1 Expression and Tumor-Infiltrating Lymphocytes Define Different Subsets of MAPK Inhibitor–Treated Melanoma Patients
Open the PDF for PD-L1 Expression and Tumor-Infiltrating Lymphocytes Define Different Subsets of MAPK Inhibitor–Treated Melanoma Patients in another window
Includes: Supplementary data
Journal Articles

BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact

Free
Helen Rizos, Alexander M. Menzies, Gulietta M. Pupo, Matteo S. Carlino, Carina Fung, Jessica Hyman, Lauren E. Haydu, Branka Mijatov, Therese M. Becker, Suzanah C. Boyd, Julie Howle, Robyn Saw, John F. Thompson, Richard F. Kefford, Richard A. Scolyer, Georgina V. Long
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (7): 1965–1977.
https://doi.org/10.1158/1078-0432.CCR-13-3122
Published: 31 March 2014
View articletitled, BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact
Open the PDF for BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact in another window
Includes: Supplementary data
Journal Articles

BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage

Free
Victoria J. Mar, Stephen Q. Wong, Jason Li, Richard A. Scolyer, Catriona McLean, Anthony T. Papenfuss, Richard W. Tothill, Hojabr Kakavand, Graham J. Mann, John F. Thompson, Andreas Behren, Jonathan S. Cebon, Rory Wolfe, John W. Kelly, Alexander Dobrovic, Grant A. McArthur
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (17): 4589–4598.
https://doi.org/10.1158/1078-0432.CCR-13-0398
Published: 02 September 2013
View articletitled, BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage
Open the PDF for BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage in another window
Includes: Supplementary data
Journal Articles

Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma

Free
Alexander M. Menzies, Lauren E. Haydu, Lydia Visintin, Matteo S. Carlino, Julie R. Howle, John F. Thompson, Richard F. Kefford, Richard A. Scolyer, Georgina V. Long
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (12): 3242–3249.
https://doi.org/10.1158/1078-0432.CCR-12-0052
Published: 14 June 2012
View articletitled, Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma
Open the PDF for Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma in another window
Includes: Supplementary data
Journal Articles

Selective BRAF Inhibitors Induce Marked T-cell Infiltration into Human Metastatic Melanoma

Free
James S. Wilmott, Georgina V. Long, Julie R. Howle, Lauren E. Haydu, Raghwa N. Sharma, John F. Thompson, Richard F. Kefford, Peter Hersey, Richard A. Scolyer
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (5): 1386–1394.
https://doi.org/10.1158/1078-0432.CCR-11-2479
Published: 01 March 2012
View articletitled, Selective BRAF Inhibitors Induce Marked T-cell Infiltration into Human Metastatic Melanoma
Open the PDF for Selective BRAF Inhibitors Induce Marked T-cell Infiltration into Human Metastatic Melanoma in another window
Includes: Supplementary data
Journal Articles

Activation of CCR9/CCL25 in Cutaneous Melanoma Mediates Preferential Metastasis to the Small Intestine

Free
Farin F. Amersi, Alicia M. Terando, Yasufumi Goto, Richard A. Scolyer, John F. Thompson, Andy N. Tran, Mark B. Faries, Donald L. Morton, Dave S.B. Hoon
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (3): 638–645.
https://doi.org/10.1158/1078-0432.CCR-07-2025
Published: 01 February 2008
View articletitled, Activation of CCR9/CCL25 in Cutaneous Melanoma Mediates Preferential Metastasis to the Small Intestine
Open the PDF for Activation of CCR9/CCL25 in Cutaneous Melanoma Mediates Preferential Metastasis to the Small Intestine in another window
Includes: Supplementary data
Journal Articles

Long-Term Protective Effect of Mature DC-LAMP+ Dendritic Cell Accumulation in Sentinel Lymph Nodes Containing Micrometastatic Melanoma

Free
Bruce Elliott, Richard A. Scolyer, Stefan Suciu, Serge Lebecque, Donata Rimoldi, Oliver Gugerli, Elena Musat, Raghwa N. Sharma, Danielle Lienard, Ulrich Keilholz, Alessandro Testori, Alexander Eggermont, Rona MacKie, Caroline Robert, Martin Cook, John F. Thompson, Eric Angevin, Alain Spatz, on behalf of the European Organization for Research and Treatment of Cancer Melanoma Group
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (13): 3825–3830.
https://doi.org/10.1158/1078-0432.CCR-07-0358
Published: 02 July 2007
View articletitled, Long-Term Protective Effect of Mature DC-LAMP+ Dendritic Cell Accumulation in Sentinel Lymph Nodes Containing Micrometastatic Melanoma
Open the PDF for Long-Term Protective Effect of Mature DC-LAMP+ Dendritic Cell Accumulation in Sentinel Lymph Nodes Containing Micrometastatic Melanoma in another window